A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph-positive chronic myelogenous leukaemia: interferon alfa-2b and hydroxyurea with or without cytosine arabinoside , preliminary results. [electronic resource]
Producer: 19920417Description: S26 p. digitalISSN:- 0959-8049
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cytarabine -- administration & dosage
- Female
- Humans
- Hydroxyurea -- administration & dosage
- Interferon Type I -- administration & dosage
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Recombinant Proteins
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.